Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Jennifer Diamond

Concepts (272)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Triple Negative Breast Neoplasms
11
2021
155
5.090
Why?
Breast Neoplasms
17
2021
2006
3.430
Why?
Pyrimidines
9
2021
414
2.800
Why?
Antineoplastic Combined Chemotherapy Protocols
14
2022
1430
2.470
Why?
Antineoplastic Agents
20
2020
2062
2.460
Why?
Neoplasms
14
2022
2163
1.960
Why?
Immunoconjugates
5
2021
87
1.960
Why?
Receptor, ErbB-2
8
2021
333
1.920
Why?
Paclitaxel
6
2022
209
1.880
Why?
Pyrazoles
6
2021
405
1.610
Why?
Camptothecin
7
2022
97
1.590
Why?
Protein Kinase Inhibitors
9
2022
889
1.560
Why?
Quinoxalines
2
2020
71
1.530
Why?
Ovarian Neoplasms
4
2020
386
1.500
Why?
Azepines
3
2020
80
1.470
Why?
Piperazines
3
2020
330
1.470
Why?
Antibodies, Monoclonal, Humanized
8
2021
667
1.350
Why?
Neutropenia
4
2022
134
1.060
Why?
Gene Expression Regulation, Neoplastic
5
2020
1216
0.920
Why?
beta Catenin
2
2020
229
0.880
Why?
Breast Neoplasms, Male
2
2018
31
0.870
Why?
Xenograft Model Antitumor Assays
10
2021
786
0.850
Why?
Cancer Care Facilities
1
2020
33
0.810
Why?
Maximum Tolerated Dose
9
2022
190
0.810
Why?
Benzoxazoles
1
2020
23
0.810
Why?
Histone Deacetylase Inhibitors
1
2022
204
0.790
Why?
Carcinoma, Lobular
2
2018
59
0.790
Why?
Lymphocytes, Tumor-Infiltrating
1
2020
117
0.780
Why?
eIF-2 Kinase
1
2019
30
0.770
Why?
Cyclin-Dependent Kinase 4
1
2018
37
0.720
Why?
Cyclin-Dependent Kinase 6
1
2018
37
0.710
Why?
Wnt Signaling Pathway
1
2019
138
0.680
Why?
Drug Resistance, Neoplasm
4
2020
707
0.670
Why?
Aurora Kinase A
4
2020
58
0.660
Why?
Female
41
2021
64422
0.660
Why?
Carcinoma, Ductal, Breast
1
2018
94
0.660
Why?
Tumor Microenvironment
1
2020
423
0.650
Why?
Pyrazines
2
2018
81
0.640
Why?
Colonic Neoplasms
1
2018
224
0.610
Why?
Neoadjuvant Therapy
1
2018
311
0.590
Why?
Humans
51
2022
119016
0.580
Why?
Angiopoietin-1
1
2015
9
0.570
Why?
Angiopoietin-2
1
2015
14
0.570
Why?
Aged
20
2021
20607
0.530
Why?
Tumor Suppressor Protein p53
3
2016
475
0.530
Why?
Uterine Cervical Neoplasms
1
2017
213
0.520
Why?
Middle Aged
23
2021
29243
0.490
Why?
Cell Line, Tumor
8
2022
2933
0.480
Why?
Tumor Suppressor Proteins
1
2015
286
0.480
Why?
Proto-Oncogene Proteins c-met
1
2013
74
0.470
Why?
Point Mutation
1
2013
239
0.450
Why?
Cell Proliferation
8
2020
2382
0.450
Why?
Adult
23
2022
32799
0.450
Why?
Treatment Outcome
12
2022
9492
0.450
Why?
Dose-Response Relationship, Drug
6
2022
2197
0.450
Why?
Recombinant Fusion Proteins
1
2015
701
0.450
Why?
Triazoles
1
2013
141
0.450
Why?
Angiogenesis Inhibitors
3
2018
221
0.430
Why?
Carcinoma, Renal Cell
1
2013
176
0.420
Why?
Mitochondria
1
2017
834
0.410
Why?
Neoplasm Recurrence, Local
4
2021
844
0.410
Why?
Clinical Trials, Phase I as Topic
2
2020
55
0.410
Why?
Colorectal Neoplasms
4
2022
636
0.410
Why?
Trastuzumab
3
2021
106
0.410
Why?
Genes, BRCA2
1
2009
24
0.390
Why?
Genes, BRCA1
1
2009
29
0.390
Why?
Neoplasm Metastasis
4
2020
617
0.390
Why?
Nuclear Proteins
1
2015
640
0.390
Why?
Biomarkers, Tumor
2
2014
1080
0.380
Why?
BRCA2 Protein
1
2009
43
0.370
Why?
Mice, Nude
5
2020
704
0.370
Why?
Pregnancy Complications, Neoplastic
1
2009
53
0.370
Why?
Molecular Targeted Therapy
3
2019
382
0.360
Why?
Aged, 80 and over
8
2020
6913
0.360
Why?
Kidney Neoplasms
1
2013
336
0.360
Why?
Chemotherapy, Adjuvant
2
2021
336
0.360
Why?
Neoplasm Staging
5
2021
1248
0.360
Why?
Thrombophilia
1
2009
76
0.360
Why?
Quinolines
2
2021
141
0.350
Why?
Aromatase Inhibitors
2
2018
54
0.350
Why?
Receptors, Progesterone
2
2021
339
0.330
Why?
DNA-Binding Proteins
1
2015
1432
0.320
Why?
Antibodies, Monoclonal
3
2020
1325
0.320
Why?
Receptors, Estrogen
2
2021
403
0.310
Why?
Mice
9
2021
15850
0.310
Why?
Antineoplastic Agents, Immunological
2
2019
163
0.310
Why?
Apoptosis
6
2022
2639
0.300
Why?
Models, Biological
1
2014
1814
0.290
Why?
Liver Neoplasms
1
2009
467
0.280
Why?
Cyclophosphamide
2
2018
237
0.260
Why?
Lung Neoplasms
1
2017
2246
0.250
Why?
Radiosurgery
2
2019
320
0.240
Why?
Doxorubicin
2
2018
316
0.240
Why?
Cyclin-Dependent Kinase 9
1
2022
10
0.230
Why?
Histone Deacetylase 1
1
2022
19
0.230
Why?
Histones
2
2022
548
0.230
Why?
Biopsy
2
2018
1076
0.230
Why?
Fluorouracil
1
2022
154
0.230
Why?
Aurora Kinases
2
2012
34
0.230
Why?
G2 Phase Cell Cycle Checkpoints
3
2022
40
0.230
Why?
Disease Progression
4
2019
2524
0.220
Why?
Topoisomerase I Inhibitors
2
2022
16
0.220
Why?
Anthracyclines
1
2021
34
0.220
Why?
Administration, Oral
3
2022
808
0.220
Why?
Animals
10
2021
35392
0.220
Why?
Taxoids
1
2021
94
0.220
Why?
Acetylation
1
2022
227
0.210
Why?
Biliary Tract Neoplasms
1
2021
21
0.210
Why?
Androstadienes
1
2021
105
0.210
Why?
Carboplatin
1
2021
143
0.200
Why?
Diarrhea
2
2019
181
0.200
Why?
Heterografts
1
2021
131
0.200
Why?
Necrosis
2
2019
231
0.200
Why?
Male
14
2021
61786
0.200
Why?
Hospitals, University
1
2021
195
0.200
Why?
Fatigue
2
2022
313
0.200
Why?
Drug Administration Schedule
3
2017
813
0.200
Why?
Histone Deacetylases
1
2022
210
0.200
Why?
Mechanistic Target of Rapamycin Complex 2
1
2020
55
0.200
Why?
Benzodiazepines
1
2021
116
0.200
Why?
Myeloid Cell Leukemia Sequence 1 Protein
1
2019
25
0.190
Why?
Mechanistic Target of Rapamycin Complex 1
1
2020
102
0.190
Why?
Medicare
2
2021
698
0.190
Why?
Immune System
1
2021
202
0.190
Why?
Kaplan-Meier Estimate
1
2021
904
0.180
Why?
Albumins
1
2019
101
0.180
Why?
Aquaporin 4
1
2019
72
0.180
Why?
Maintenance Chemotherapy
1
2018
25
0.180
Why?
Antibodies, Bispecific
1
2018
29
0.180
Why?
Tumor Cells, Cultured
1
2020
1008
0.180
Why?
Nausea
1
2018
116
0.170
Why?
Aminopyridines
1
2018
91
0.170
Why?
Vascular Endothelial Growth Factor A
2
2018
531
0.170
Why?
Mastectomy
1
2018
117
0.170
Why?
Breast
1
2018
151
0.170
Why?
Benzimidazoles
1
2018
146
0.160
Why?
Topotecan
1
2017
13
0.160
Why?
Mice, Inbred BALB C
1
2020
1328
0.160
Why?
Purines
1
2018
167
0.160
Why?
Drug Therapy, Combination
1
2020
1018
0.160
Why?
Radiotherapy, Adjuvant
1
2018
196
0.160
Why?
Isoflavones
1
2017
26
0.160
Why?
Calcium-Binding Proteins
1
2018
222
0.160
Why?
Carbolines
1
2017
34
0.160
Why?
Heterocyclic Compounds, 4 or More Rings
1
2017
15
0.160
Why?
Disease Models, Animal
2
2021
3894
0.160
Why?
Imidazoles
1
2018
264
0.160
Why?
Inhibitory Concentration 50
2
2016
83
0.160
Why?
Immunotherapy
1
2021
478
0.160
Why?
Nanoparticles
1
2021
336
0.160
Why?
Survival Analysis
1
2020
1420
0.150
Why?
Insulin-Like Growth Factor I
1
2018
293
0.150
Why?
Neoplasms, Radiation-Induced
1
2016
76
0.150
Why?
Neoplasms, Second Primary
1
2016
75
0.150
Why?
GPI-Linked Proteins
1
2016
56
0.150
Why?
Hypertension
2
2018
1220
0.150
Why?
Cell Survival
1
2019
1137
0.150
Why?
Retrospective Studies
3
2021
12249
0.140
Why?
Adaptor Proteins, Signal Transducing
1
2018
392
0.140
Why?
Tumor Protein p73
1
2015
17
0.140
Why?
Antibodies, Neoplasm
1
2015
32
0.140
Why?
Hodgkin Disease
1
2016
117
0.140
Why?
Risk Reduction Behavior
1
2016
221
0.140
Why?
Phosphorylation
1
2019
1754
0.130
Why?
Maytansine
1
2014
14
0.130
Why?
Pyridines
1
2018
501
0.130
Why?
Demography
1
2015
292
0.130
Why?
Brain Edema
1
2014
66
0.130
Why?
Randomized Controlled Trials as Topic
1
2019
1222
0.130
Why?
Drug Interactions
1
2015
401
0.130
Why?
Survival Rate
2
2019
1874
0.120
Why?
Threonine
1
2013
52
0.120
Why?
Protein Kinases
1
2015
336
0.120
Why?
Sulfones
1
2014
105
0.120
Why?
Analgesics, Opioid
1
2021
780
0.120
Why?
Glycine
1
2014
167
0.120
Why?
Tumor Stem Cell Assay
1
2012
39
0.120
Why?
Drug Evaluation, Preclinical
1
2013
198
0.120
Why?
Methionine
1
2013
158
0.120
Why?
Heterozygote
1
2013
257
0.120
Why?
Drug Design
1
2013
172
0.120
Why?
Computational Biology
1
2015
489
0.110
Why?
Treatment Failure
1
2013
343
0.110
Why?
Disease-Free Survival
1
2014
692
0.110
Why?
In Situ Hybridization, Fluorescence
1
2013
343
0.110
Why?
Time Factors
2
2020
7099
0.110
Why?
Cellular Senescence
1
2012
147
0.110
Why?
Neovascularization, Pathologic
1
2013
296
0.110
Why?
Carcinoma in Situ
1
2011
47
0.110
Why?
Cluster Analysis
1
2012
472
0.110
Why?
Cell Transformation, Neoplastic
1
2013
339
0.100
Why?
Vascular Endothelial Growth Factor Receptor-2
1
2010
88
0.100
Why?
Risk Assessment
1
2020
3250
0.100
Why?
Brain Neoplasms
2
2019
1000
0.100
Why?
Receptor Protein-Tyrosine Kinases
1
2013
282
0.100
Why?
Mutation
2
2012
3468
0.100
Why?
United States
3
2021
12886
0.100
Why?
Colorado
1
2020
4577
0.100
Why?
Sequence Analysis, DNA
1
2013
741
0.100
Why?
Tumor Burden
1
2010
289
0.100
Why?
Pregnancy Trimester, Second
1
2009
81
0.090
Why?
Mastectomy, Segmental
1
2009
91
0.090
Why?
Keratinocytes
1
2010
244
0.090
Why?
Poly(ADP-ribose) Polymerase Inhibitors
1
2009
64
0.090
Why?
Pregnancy Trimester, First
1
2009
124
0.090
Why?
Clinical Trials as Topic
2
2013
1022
0.090
Why?
Lymph Node Excision
1
2009
156
0.090
Why?
Apoptosis Regulatory Proteins
1
2009
215
0.090
Why?
Infusions, Intravenous
2
2019
407
0.080
Why?
Cell Adhesion Molecules
2
2019
188
0.080
Why?
Antigens, Neoplasm
2
2019
232
0.080
Why?
Risk Factors
1
2020
9266
0.080
Why?
Risk
1
2009
956
0.080
Why?
Prognosis
2
2018
3592
0.080
Why?
Gene Expression Profiling
1
2012
1590
0.070
Why?
Cell Cycle
2
2018
594
0.070
Why?
Combined Modality Therapy
2
2019
1230
0.060
Why?
Mesylates
1
2022
6
0.060
Why?
Ataxia Telangiectasia Mutated Proteins
1
2022
63
0.060
Why?
Signal Transduction
2
2014
4919
0.060
Why?
Chimerism
1
2021
29
0.050
Why?
Lymphoid Tissue
1
2021
65
0.050
Why?
Lymphocyte Subsets
1
2021
84
0.050
Why?
Liver
1
2009
1873
0.050
Why?
Mice, SCID
1
2021
372
0.050
Why?
SEER Program
1
2021
208
0.050
Why?
Mice, Inbred NOD
1
2021
597
0.050
Why?
M Phase Cell Cycle Checkpoints
1
2018
23
0.050
Why?
Infant, Newborn
1
2009
5203
0.040
Why?
Tissue Distribution
1
2018
366
0.040
Why?
Anemia
1
2019
168
0.040
Why?
Pregnancy
1
2009
5546
0.040
Why?
Retreatment
1
2016
70
0.040
Why?
Cetuximab
1
2016
98
0.040
Why?
Platinum
1
2016
38
0.040
Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2016
122
0.040
Why?
Neoplasm Transplantation
1
2016
263
0.040
Why?
Drug Screening Assays, Antitumor
1
2016
193
0.040
Why?
Hematopoietic Stem Cell Transplantation
1
2021
572
0.040
Why?
Proto-Oncogene Proteins p21(ras)
1
2016
238
0.040
Why?
History, Ancient
1
2015
45
0.040
Why?
Databases, Genetic
1
2015
173
0.030
Why?
Biomarkers
2
2016
3583
0.030
Why?
Opioid-Related Disorders
1
2021
360
0.030
Why?
DNA Damage
1
2017
373
0.030
Why?
Mice, Knockout
1
2021
2862
0.030
Why?
Phenotype
1
2021
2938
0.030
Why?
Drug Combinations
1
2013
309
0.030
Why?
Drug-Related Side Effects and Adverse Reactions
1
2015
233
0.030
Why?
Intracellular Signaling Peptides and Proteins
1
2015
407
0.030
Why?
Immunohistochemistry
1
2016
1802
0.030
Why?
Biopsy, Needle
1
2011
201
0.030
Why?
Cohort Studies
1
2021
5129
0.030
Why?
HT29 Cells
1
2010
38
0.030
Why?
Transcription, Genetic
1
2017
1472
0.020
Why?
Ki-67 Antigen
1
2010
110
0.020
Why?
Cell Cycle Proteins
1
2014
573
0.020
Why?
ErbB Receptors
1
2013
575
0.020
Why?
Enzyme Inhibitors
1
2014
941
0.020
Why?
Capillary Permeability
1
2010
163
0.020
Why?
Protein-Tyrosine Kinases
1
2013
456
0.020
Why?
Proto-Oncogene Proteins
1
2014
726
0.020
Why?
Patient Selection
1
2013
710
0.020
Why?
Patient Satisfaction
1
2013
621
0.020
Why?
Follow-Up Studies
1
2018
5000
0.020
Why?
Membrane Proteins
1
2015
1110
0.020
Why?
Positron-Emission Tomography
1
2010
309
0.020
Why?
Algorithms
1
2015
1552
0.020
Why?
Magnetic Resonance Imaging
1
2019
3266
0.020
Why?
Tomography, X-Ray Computed
1
2016
2431
0.020
Why?
Brain
1
2014
2787
0.010
Why?
Young Adult
1
2014
11181
0.010
Why?
Diamond's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2023 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)